Analysis of Risk Factors for Developing Tuberculosis in Patients Who Received Prophylactic Latent Tuberculosis Infection Treatment with Experience of Biologic Medications.
Itagaki M, Iketani O, Enoki Y, Chuang VTG, Taguchi K, Uno S, Uchida S, Namkoong H, Uwamino Y, Takano Y, Hasegawa N, Matsumoto K.
Itagaki M, et al. Among authors: taguchi k.
Biol Pharm Bull. 2023;46(12):1832-1837. doi: 10.1248/bpb.b23-00521.
Biol Pharm Bull. 2023.
PMID: 38044103
Free article.
The percentage of patients who received prednisolone at a dose of 15 mg for more than 1 month was higher in those who developed TB than in those who did not (40.0 vs. 7.1%, p = 0.054); however, this difference was not statistically significant. Regular monitoring of TB is necessa …
The percentage of patients who received prednisolone at a dose of 15 mg for more than 1 month was higher in those who developed TB than in t …